A detailed history of Profit Investment Management, LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Profit Investment Management, LLC holds 220,324 shares of VNDA stock, worth $1.15 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
220,324
Previous 389,274 43.4%
Holding current value
$1.15 Million
Previous $1.64 Million 44.88%
% of portfolio
0.51%
Previous 0.94%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

SELL
$3.47 - $4.61 $586,256 - $778,859
-168,950 Reduced 43.4%
220,324 $905,000
Q4 2023

Jan 12, 2024

BUY
$3.38 - $4.58 $210,496 - $285,228
62,277 Added 19.05%
389,274 $1.64 Million
Q3 2023

Oct 05, 2023

SELL
$4.28 - $6.57 $7,151 - $10,978
-1,671 Reduced 0.51%
326,997 $1.41 Million
Q2 2023

Jul 10, 2023

SELL
$5.9 - $6.95 $24,750 - $29,155
-4,195 Reduced 1.26%
328,668 $2.17 Million
Q1 2023

Apr 10, 2023

SELL
$6.18 - $7.99 $12,922 - $16,707
-2,091 Reduced 0.62%
332,863 $2.26 Million
Q3 2022

Oct 13, 2022

BUY
$9.44 - $11.76 $500,924 - $624,032
53,064 Added 18.82%
334,954 $3.31 Million
Q1 2022

Apr 20, 2022

BUY
$10.84 - $16.55 $475,117 - $725,386
43,830 Added 18.41%
281,890 $3.19 Million
Q4 2021

Jan 19, 2022

BUY
$15.69 - $21.14 $2.51 Million - $3.38 Million
159,906 Added 204.6%
238,060 $3.74 Million
Q3 2021

Oct 08, 2021

SELL
$15.35 - $21.27 $2.74 Million - $3.79 Million
-178,392 Reduced 69.54%
78,154 $1.34 Million
Q1 2021

Apr 14, 2021

SELL
$13.42 - $20.28 $71,729 - $108,396
-5,345 Reduced 2.04%
256,546 $3.85 Million
Q3 2020

Nov 09, 2020

BUY
$9.32 - $12.02 $660,797 - $852,230
70,901 Added 37.12%
261,891 $2.53 Million
Q2 2020

Jul 16, 2020

BUY
$9.66 - $12.02 $828,402 - $1.03 Million
85,756 Added 81.49%
190,990 $2.19 Million
Q1 2020

Apr 23, 2020

BUY
$7.5 - $16.8 $789,255 - $1.77 Million
105,234 New
105,234 $1.09 Million

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $296M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Profit Investment Management, LLC Portfolio

Follow Profit Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profit Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profit Investment Management, LLC with notifications on news.